The Globe is reporting that Genzyme’s Allston plant, which shut down earlier this month due to a virus contaminating one of the plant’s six bioreactors, will be closed longer than expected.
The Cambridge-based biotech now says the plant will be shut down six to eight weeks. Genzyme has decided to clean the entire facility, rather than just the affected area.
Genzyme initially said production of the drugs made at the facility, Cerezyme and Fabrazyme, would be on hold for four and six weeks, respectively.
Posted by Brendan Lynch
RSS Feeds
